Nureca Ltd. · NSE:NURECA
Nureca — Q1 FY26 Earnings Presentation
26 slides from Nureca's earnings presentation, Jul 15, 2025
Slide 1: Exchange filing cover letter for Investor Presentation Q1 FY26
NURECA www.nureca.com Dated - 15.07.2025 BSE LIMITED NATIONAL STOCK EXCHANGE OF INDIA LIMITED Corporate Relations Department Listing Department Phiroze Jeejeebhoy Towers Exchange Plaza, 5th Floor, Plot no. C/1 Dalal Street, Fort G Block, Bandra Kurla Complex, Bandra (E) Mumbai-400001 Mumbai-400051 S
Slide 2: Investor Presentation Q1 FY 26
NURECA Investor Presentation Q1 FY 26 ‘N' ey Dr Trust Ranked India’s No. 1 Home Healthcare & Wellness Brand www.nureca.com
Slide 3: Disclaimer
NURECA *olsciimer The Presentation is to provide the general background information about the Company’s activities as at the date of the Presentation. The information contained herein is for general information purposes only and based on estimates and should not be considered as a recommendation tha
Slide 4: Our Vision Our Mission
NURECA Our Vision To be a global leader in healthcare innovation, empowering individuals to take control of their well-being through cutting-edge technology, accessible solutions, and an unwavering commitment to excellence in quality and service. Our Mission To provide world-class healthcare solutio
Slide 5: Table of Contents
Table of Contents - Highlights of Q1 & FY 26 Business Highlights - Business Performance- Q1 & FY 26 Industry Landscape - Growth Drivers
Slide 6: Highlights of Q1 FY26
NURECA Highlights of Q'1 FY26 . DEC 2024-DEC 2025 INDIA 1. Current Quarter Marks Highest Revenue in last consecutive 10 Quarters, Outpacing Even Seasonal Peaks 2. Revenue grew in Quarter YoY by 70% , increasing from 220.26 crore to 234.17 crore. 3. Revenue grew by 8% in Quarter QoQ, increasing from
Slide 7: Financial Performance
NURECA We are a Digital First Healthcare Company with more than 93% revenue generated by Online sales Nureca is a debt-free, asset light company and has a healthy liquidity position. Financial Performance Revenue from Operations EBITDA Profit After Tax e QIFY 26 - INR 465 Mn ® QIFY 26 -INR342Mn e QI
Slide 8: Business Highlights
NURECA Business Highlights
Slide 9: 3P Interplay Generating Business MOAT
NURECA 3P Interplay Generating Business MOAT (3P -Product - Placement - Promotion) Internal Strengths Curated Over the Years Across Product Design, Supply Chain, Distribution and Marketing is Onerous to Replicate q Sustained focus on Innovation and Quality Products Integrated Manufacturing Ecosystem
Slide 10: Strategic Pillars
Strategic Pillars D2C growth Omnipresence Manufacturing Connected Health Expand our already strong Establish pan India sales Building a strong manufacturing Transform lives of our users presence online by network with expansive reach base in India with focus on quality, through our Connected innovat
Slide 11: D2C growth
NURECA l. D2C growth Our growing digital customer base Our customer base has grown exceptionally over the last 5 years which is a result of remarkable quality of our o 93% £ 2 products that led to word-of-mouth marketing by our loyal customer base. Currently, our products have more Revenue Contribut
Slide 12: Diving into Our Products Portfolio
NURECA Diving into Our Products Portfolio é Ié Air Massagers Compression Massager Manipol supervolt Go Gun Dynamo Rechargeable Gun ~ FOOt, Leg and Calf with Heat DVT Body Massager Weighing & Kitchen e Scales Platinum 8 Electrode Digital Legend SmartScale |/ es scale Unbeatable Scale Electronic Kitch
Slide 13: Orthopedic, Mother & Baby Care and other products
Orthopedic \ ‘’ \ R nge' | Leg Elevation Maternity Backrest Neck Pillow for Wedge Pillow Support Pillow Wedge Pillow travelling ) N St = \ 1 Orthopedic “ \ Cooling Gel | 1 ' ' Range-1I Neck rest Car Neck Stretcher Neck Stretcher Memory Memory Foam Contoured" Orthopedic I ' ' Pillow with heat without
Slide 14: New Launches
New Launches Mustard seed Baby Head Shaping Pillow Nano Junior Compressor Steamer-Lux Noir Child Friendly Nebulizer A\ y Shiatsu Massager-Cervical Gun Massager : TOuch Spondylosis Muscle Pain Shiatsu Massager-with Infrared Dynamo Relief Kneading Nodes
Slide 15: Manufacturing
Il. Manufacturing Our wholly owned manufacturing subsidiary Nureca Technologies Pvt Limited , stared operations in Apr'22. USFDA Registration No.: 3036779619 Medical Products categories manufactured at NTPL: 1. Blood Pressure Monitors Nebulizers N Electric Massagers w Oral and Infrared Thermometers
Slide 16: Omnipresence
lll. Omnipresence Expanding Offline Distribution Over the years, our brand, Dr Trust, has garnered substantial recognition and commendation across e-commerce platforms. By capitalizing on this positive momentum, we anticipate a notable upswing in our retail trade network. We are in the process of re
Slide 17: Connected Health
NURECA Good morning! Vishal v IV. Connected Health v 401230 Dr Trust 360 is not just an app, its a Quick Measure comprehensive health management companion that empowers users to take control of their Weight i3 health through technology i Weight dli @ Nood quantiy hoip? Tgm | 25 cal 60 /61.0kg By con
Slide 18: Dr Trust 360 Freemium Connected Health app
DrTrust 366 Freemium Connected Health app Our unified app is a Freemium model, where users are able to subscribe for Pro features like Advanced health reports, curated diet plans, calorie & water intake tracking, family & caregiver alerts on Whatsapp F F t Allows Users to access basic features at no
Slide 19: Rewards & Recognition
Rewards & Dr Trust Recognition A R .. Brand in India : %‘ > Dr Trust, Nureca's flagship brand, has been ranked by customers as India’'s number one brand in the category of Home Healthcare and Wellness. > Dr Trust awarded in Best Healthcare Brands 2021 by Economic Times, Premium Prestigious Brands 20
Slide 20: Business Performance
Business Performance
Slide 21: Key Performance Indicators (Consolidated)
NURECA Key Performance Indicators (Consolidated) Revenue from Operations( ¥ Crore) EPS (%)o 255.5 08 — | 0ss -8.3 -1.8 | | | | | | s T . o ity EESEmNiGD 2021 2122 2223 2324 2425 25-26 (Till Q1) PAT (Z Crore) Fixed Asset (¥Crore) 46.4 - 152 10.6 i 9.0 7.4 0.9 0.8 1.8 8.3 1 L | L 1 | 20-21 21-22 2223
Slide 22: Industry Landscape
Industry Landscape=7
Slide 23: Market Size for Healthcare Products in India & Neighboring Countries
NURECA Market Size for HealthCare Products in India & Neighboring Countries, 2025-2030E (in Crore) Self Monitoring Glucose Devices CAGR 2025-2030E (9.9%) 5203 W Digital and Infrared Thermometers M Humidifiers and Steamers Pulse Oximeters 1408 Nebulizers 3559 1315 I Weighing & Kitchen Scales* 3240 12
Slide 24: Digitization of Sales Process Generated a Virtuous Flywheel
NURECA Digitization of Sales Process has Generated a Virtuous Flywheel enabling Faster Speed to Market Product Design E Manufacturing Ecosystem =2 Distribution E Marketing Digitization Our Data Centric Approach allows us to : Improved Customer e leveraging Consumer InvestmentinD2C & Engagements Insi
Slide 25: Growth Drivers Going Forward
NURECA Growth Drivers Going Forward Boosting Quick Commerce Reach and Market Penetration Driving In-house Manufacturing with Cutting-edge DrTrust USA Quality Innovations Drive Market Growth with New Product Launches and thereby Increase value proposition to customers Drive Deeper Market Penetration
Slide 26: Thank You
NURECA THINK. FEEL. CREATE Thank You Contact Us Investor Relations Website Nishu Kansal Corporate: www.Nureca.com investor@nureca.com Ecom Store: www.drtrust.in